New Study Tells Us Which Antidepressants Work the Best

Here’s some news for all my fellow depressives. Aaron Carroll points today to a massive new study on the effectiveness of antidepressants:

The reassuring news is that all of the antidepressants were more effective than placebos….Further good news is that smaller trials did not have substantially different results from larger trials….It also did not appear that industry sponsoring of trials correlated with significant differences in response or dropout rates.

….The bad news is that even though there were statistically significant differences, the effect sizes were still mostly modest. The benefits also applied only to people who were suffering from major depression, specifically in the short term. In other words, this study provides evidence that when people are found to have acute major depression, treatment with antidepressants works to improve outcomes in the first two months of therapy.

Just to clarify this, this was a metastudy focused solely on studies of antidepressants for major depression. It didn’t conclude anything one way or the other about how well these drugs work for those with moderate depression. Also, they warn that Prozac is probably the only antidepressant that works for children and teenagers.

And now it’s time for the payoff to my clickbait headline. How does your antidepressant perform? Here’s the chart:

The left chart shows how well each antidepressant worked. The right chart shows how well people tolerated it. For example, I use venlafaxine (Effexor), which appears to be pretty effective (odds ratio = 1.78). Its tolerability, as measured by how many people dropped out of studies, is about the same as a placebo.

As always, this is just raw data. Different drugs work differently for different people. Only you and your doctor can decide for sure what works best for you.

What’s independent journalism worth to you?

Our news will always be free to read, watch, and listen to online. But what is its value?

Unbiased reporting on the issues that billionaire-owned newsrooms won’t touch. Fearless research into the dark corners of government and corporations. Ferociously fact-checked news that focuses on the facts, and the facts alone.

It IS free for you and every reader, viewer, and listener to utilize. But it’s not free for our team to make. So, what’s it worth to you? Let us know by making a donation: Make a one-time donation today to support this work. Or make a monthly sustaining donation to help us plan for the future.

Whatever you choose, know that you’re supporting more independent, investigative journalism in a time when we need it most.

What’s independent journalism worth to you?

Our news will always be free to read, watch, and listen to online. But what is its value?

Unbiased reporting on the issues that billionaire-owned newsrooms won’t touch. Fearless research into the dark corners of government and corporations. Ferociously fact-checked news that focuses on the facts, and the facts alone.

It IS free for you and every reader, viewer, and listener to utilize. But it’s not free for our team to make. So, what’s it worth to you? Let us know by making a donation: Make a one-time donation today to support this work. Or make a monthly sustaining donation to help us plan for the future.

Whatever you choose, know that you’re supporting more independent, investigative journalism in a time when we need it most.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

INDEPENDENT. BECAUSE OF YOU.

Mother Jones has no billionaires calling the shots—just readers like you making fearless reporting possible

Donate